<SEC-DOCUMENT>0001144204-13-043707.txt : 20130808
<SEC-HEADER>0001144204-13-043707.hdr.sgml : 20130808
<ACCEPTANCE-DATETIME>20130807180645
ACCESSION NUMBER:		0001144204-13-043707
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20130807
FILED AS OF DATE:		20130808
DATE AS OF CHANGE:		20130807

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CHEMICAL & MINING CO OF CHILE INC
		CENTRAL INDEX KEY:			0000909037
		STANDARD INDUSTRIAL CLASSIFICATION:	MINING, QUARRYING OF NONMETALLIC MINERALS (NO FUELS) [1400]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			F3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	033-65728
		FILM NUMBER:		131019329

	BUSINESS ADDRESS:	
		STREET 1:		EL TROVADOR 4285, 6TH FLOOR
		STREET 2:		LAS CONDES
		CITY:			SANTIAGO CHILE
		STATE:			F3
		ZIP:			00000
		BUSINESS PHONE:		5624252485
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>v352256_6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">UNITED STATES OF AMERICA</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">SECURITIES AND EXCHANGE COMMISSION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Washington, D.C.
20549</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>FORM 6-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">REPORT OF FOREIGN ISSUER</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">PURSUANT TO RULE 13A-16 OR 15D-16</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">OF THE SECURITIES AND EXCHANGE
ACT OF 1934</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Includes the free translation
of information presented by Sociedad Qu&iacute;mica y Minera de Chile <BR>
S.A. to the Chilean Securities and Insurance Commission (<I>Superintendencia
de Valores y <BR>
Seguros de Chile) </I>on August 06, 2013.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><U>SOCIEDAD QUIMICA Y MINERA
DE CHILE S.A.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Exact name of registrant as
specified in its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><U>CHEMICAL AND MINING COMPANY
OF CHILE INC.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Translation of registrant's
name into English)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><U>El Trovador 4285, Santiago,
Chile (562) 2425-2000</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Address and phone number of
principal executive offices)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 53.5pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 53.5pt 0pt 0; text-align: justify">Indicate by check mark whether
the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 53.5pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 53.5pt 0pt 0.25in; text-align: justify">Form 20-F <FONT STYLE="font-family: Wingdings">&#120;</FONT>&#9;Form
40-F <FONT STYLE="font-family: Wingdings">&#168;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 53.5pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 53.5pt 0pt 0; text-align: justify">Indicate by check mark whether
the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission
pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 53.5pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 53.5pt 0pt 0.25in; text-align: justify">&#9;Yes <FONT STYLE="font-family: Wingdings">&#168;
</FONT>No <FONT STYLE="font-family: Wingdings">&#120;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 53.5pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 53.5pt 0pt 0; text-align: justify">If &quot;Yes&quot; is marked,
indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82_________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-indent: 0.5in; text-align: right">Santiago,
6th August 2013.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: left; margin-bottom: 0pt">Mr.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: left; margin-bottom: 0pt">Hern&aacute;n L&oacute;pez
B.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: left; margin-bottom: 0pt">Superintendent,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: left; margin-bottom: 0pt">Superintendence of Securities
and Insurance</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: left; margin-bottom: 0pt">Avda . Libertador Bernardo
O'Higgins N&ordm;1449 Santiago</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: left; margin-bottom: 0pt">Mr. Superintendent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 65.95pt 0pt 42.4pt; text-align: justify">We have received your
Notification (Oficio Ordinario) N.17.323, dated August 5, 2013.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 65.95pt 0pt 42.4pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 7.15pt">In relation to the contents of the Notification,
we state the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 7.85pt"></TD><TD STYLE="width: 33.85pt"><FONT STYLE="color: #1F161A">1.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 68.9pt 0pt 42.55pt; text-align: justify">Sociedad Qu&iacute;mica and Minera of Chile S.A. (&ldquo;SQM&rdquo; or &ldquo;The
Company&rdquo;) is a minor player in the international production and marketing of potassium chloride (KCL). Its KCL sales represent
less than 3% of world demand, and the Company is not part of any KCL distribution association. Therefore, SQM has no capacity whatsoever
to influence the variations of the international prices of KCL.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 6.8pt"></TD><TD STYLE="width: 34.2pt"><FONT STYLE="color: #1F161A">2.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 68.9pt 0pt 42.55pt; text-align: justify">On July 30 of this year, the Russian company &quot;Uralkali&quot; informed the markets about its decision
to put an end to the KCL sales agreement it had with the Byelorussian company &quot;Belaruskali&quot; and, though it pointed out
that it might re-activate said agreement at any time, it also said that it would increase its KCL production and sales volumes.
This was an autonomous decision from &quot;Uralkali&quot; which had not been anticipated in the markets. It may be pointed out,
additionally, that the markets have no influence or control whatsoever over such decisions.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 6.05pt"></TD><TD STYLE="width: 36.5pt; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">The above news had significant effects on the prices of the shares of the other KCL production and sales companies
worldwide. Said shares - including SQM&rsquo;s shares - decreased in value by approximately 17% during such day.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 68.9pt 0pt 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 6.05pt"></TD><TD STYLE="width: 36.5pt"><FONT STYLE="color: #1F161A">3.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 68.9pt 0pt 42.55pt; text-align: justify">The KCL industry worldwide is made up of more than 10 relevant companies that operate mainly in Germany, Belarus,
Canada, the United States of America, Israel, Jordan, Popular Republic of China and Russia. For the current year, the global demand
for KCL could amount to approximately 55 million tons and its total value may be approximately US$ 20 billion.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-indent: -36.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 6.05pt"></TD><TD STYLE="width: 36.5pt; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">It is important to remember &ndash; so that things may be put into context - that, in international stock
exchanges during the first half of this year, the transactions of the shares of just three of these companies - &quot;Potash Corp&quot;,
&quot;Mosaic&quot; and &quot;Agrium&quot; &ndash; were in excess of, (in US$), to <U>more than twice</U> the value of the <U>total
transactions of all shares</U> traded in the Santiago Stock Exchange during the same period. In light of the above, one may easily
understand why the KCL industry is being closely observed and followed by international investment banks and analysts, and is the
subject of countless reports and studies, all of which are available to the public. Said reports and publications are being updated
closely, and they explain, in detail, the various factors that can affect the KCL industry in general, and its main players, in
particular.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 68.9pt 0pt 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 68.9pt 0pt 42.55pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 68.9pt 0pt 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 9.25pt"></TD><TD STYLE="width: 35.1pt"><FONT STYLE="color: #1F161A">4.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 68.9pt 0pt 42.55pt; text-align: justify">SQM&rsquo;s &quot;June 2013 IFRS Financial Statements&quot; should be available
for evaluation by the Company&rsquo;s Board of Directors in the Board Session to be held on Tuesday, August 27th. The following
information is based &ndash; unless otherwise stated - on the Company&rsquo;s &quot;March 2013 IFRS Financial Statements&quot;.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 71.05pt 0pt 44.35pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 9.25pt"></TD><TD STYLE="width: 35.1pt"><FONT STYLE="color: #1F161A">5.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 68.9pt 0pt 42.55pt; text-align: justify">The &quot;March 2013 IFRS Financial Statements&quot; clearly state - in Note 1.4 - that SQM has six Main business
lines. Clearly, the &ldquo;Potassium&rdquo; business line (potassium chloride and potassium sulphate) &ndash; is directly linked
to changes in KCL market conditions. Similarly, the prices of potassium nitrate (KNO3), which is part of the &quot;Specialty Plant
Nutrients&quot; and &quot;Industrial Chemicals&quot; business lines, are indirectly linked to the prices of KCL. On the one hand,
KCL is an input for the production of KNO3 and its price affects the production costs of KNO3. On the other hand &ndash; although
there is no significant direct competition between the KNO3 and the KCL markets, the lower prices of the latter product could possibly
affect the price scenarios in the KNO3 markets. Moreover, the use of KCL as an input for the production of KNO3 and the characteristics
of the KNO3 market are clearly described in SQM&rsquo;s &quot;Form 20-F Report&quot;, in SQM&rsquo;s Annual Report and in &quot;SQM
Corporate Presentation&quot; which are available in both English and Spanish, in SQM&rsquo;s webpage (www.sqm.com).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 71.5pt 0pt 43.6pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 9.25pt"></TD><TD STYLE="width: 35.1pt; text-align: left"><FONT STYLE="color: #1F161A">6.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 68.9pt 0pt 42.55pt; text-align: justify">In Note 26.3 of the &quot;March 2013 IFRS Financial Statements&quot;, it is stated that revenue from &quot;Potassium&quot;
amounted to approximately US$ 152.9 million, approximately 24.5% of SQM&rsquo;s total revenue in said quarter.&#9;In the case of
&quot;Specialty Plant Nutrients&quot;, the same Note states that revenue from said products amounted to &asymp; US$ 196.7 million,
which represents approximately 31.6% of SQM&rsquo;s total sales during said quarter, and also that revenue from &quot;Industrial
Chemicals&quot; amounted to approximately US$ 70.9 million which represents approximately 11.4% of total sales in said period.
Moreover, Note 26.3 of SQM&rsquo;s &quot;December 2012 IFRS Financial Statements&quot; indicates the respective amounts for &quot;Potassium&quot;,
&quot;Specialty Plant Nutrients&quot; and &quot;Industrial Chemicals&quot; for the year 2012 .</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 7.1pt"></TD><TD STYLE="width: 36.1pt"><FONT STYLE="color: #1F161A">7.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 68.9pt 0pt 42.55pt; text-align: justify">The
&quot;<FONT STYLE="font: 10pt Times New Roman, Times, Serif">March 2013 IFRS Financial Statements&quot;
also state, in Note 26.3, that the sales costs associated to &quot;Potassium&quot; amounted to approximately US$ 104.5 million,
which represents approximately 27.2% of SQM&rsquo;s total sales costs. Similarly, for &quot;Specialty Plant Nutrients&quot;, said
Financial Statements indicate that sales costs amounted to &asymp; US$ 138.6 million and that sales costs for &quot;Industrial
Chemicals&quot; amounted to approximately US$ 48.5 million, which represent apprximately 36% and approximately 12.6% of the Company&rsquo;s
total sales costs in that period. Similarly, Note 26.3 of SQM&rsquo;s </FONT> &quot;December
2012 IFRS Financial Statements&quot; indicate the values corresponding to the year 2012<SUP>1</SUP></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P></TD></TR>
</TABLE>
<P STYLE="margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="margin: 0pt 0; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 7.95pt"></TD><TD STYLE="width: 34.6pt"><FONT STYLE="color: #1F161A">8.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 68.9pt 0pt 42.55pt; text-align: justify">As a result &ndash; simply for illustrative purposes, and based on the information available on March 31<SUP>st</SUP>
2013 - the eventual decrease of 10% in the prices of the &quot;Potassium&quot; product line could have a negative effect of approximately
US$ 15.3 million in &quot;Gross Profits&quot; for the first quarter of 2013, which could represent a decrease of approximately
6.4% in the &quot;Gross Profits&quot; for said period. However - and also in light of the fact that SQM expects to increase sales
volumes by approximately 10% in the &quot;Potassium&quot; business line during the second quarter compared to volumes sold during
the first quarter of this year &ndash; accrued sales in the first 6 months of 2013 should be on the order of approximately US$
320 million. Therefore, the negative effect of an eventual decrease of 10% in prices would be about US$ 32.0 million in &quot;Gross
Profits&quot; for the first semester of this year.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 73.7pt 0pt 42.55pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 7.95pt"></TD><TD STYLE="width: 34.6pt; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">The estimated values of the above simulation may vary significantly for 2013, to the extent that sales volumes
increase during the second semester compared to the first semester of this year. The current uncertainties in the &quot;Potassium&quot;
market make it difficult to provide an exact estimate for the second semester.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 7.95pt"></TD><TD STYLE="width: 34.6pt; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">Also, it is particularly difficult to estimate the effect of a possible drop in the price of KCL on the price
of KNO3. In principle, if a KNO3 producer has to buy KCL &ndash; but this is not the case for SQM, because the Company produces
its own KCL &ndash; and in a scenario of a approximately 10% decrease, in the price of KCL (based on a 2013 first-quarter price
of approximately USS$ 420 per ton of dry product) and an approximate consumption factor of 0.8 tons of KCL per ton of KNO3 (production
process factor), the costs of KNO3 would decrease approximately by US$ 33.6 per ton (420 x 0.1 x 0.8), and this decrease may or
may not be passed on to the sale price. The average selling price of SQM&rsquo;s KNO3 in the first quarter of 2013 was approximately
US$ 955 per ton and, assuming that such savings is fully passed on to the sale price,
there may eventually be a decrease of approximately 3.5% in the KNO3 sales price in case of a reduction of approximately
10% in the price of KCL.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0">SQM&rsquo;s original KCL and KNO3 production plans remain unchanged for the</P>

<P STYLE="margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0"></P>

<HR ALIGN="LEFT" NOSHADE SIZE="1" STYLE="color: Black; width: 25%; margin-top: 3pt; margin-bottom: 3pt">
<P STYLE="margin: 0pt 0"></P>

<P STYLE="margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 39.3pt 0pt 0; text-align: justify"><SUP>1</SUP><FONT STYLE="font: 10pt Times New Roman, Times, Serif">
Sales costs include total direct and indirect costs (excluding administration costs), distribution costs, depreciation and
transportation and logistics costs to get the product to the final client. Additionally, it should be kept in mind that,
unlike the great majority of KCL producers, SQM has a joint process with three final co-products: KCL, potassium sulphate and
lithium carbonate. Therefore, in order to analyze SQM&rsquo;s competitive position, it is important to jointly consider the
margins of the three different products. Similarly, in the case of KNO3 - which uses KCL and sodium nitrate as raw materials
- sodium nitrate is produced jointly with &ndash; and as a co-product with iodine.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 69.3pt 0pt 41.4pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 69.3pt 0pt 41.4pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 69.3pt 0pt 41.4pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 69.3pt 0pt 41.4pt; text-align: justify"></P>

<P STYLE="margin: 0pt 0">coming months. Possible decreases in KCL prices should not have direct effects on production costs during
the period.<SUP>2</SUP></P>


<P STYLE="margin-top: 0pt; text-align: left; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 69.3pt 0pt 41.4pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 69.3pt 0pt 41.4pt; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 9.45pt"></TD><TD STYLE="width: 33.75pt"><FONT STYLE="color: #1F161A">9.</FONT></TD><TD STYLE="text-align: justify; padding-right: 68.9pt">The markets have not seen relevant KCL transactions (as far as is known
in the public domain) in the days after the &quot;Uralkali&quot; announcement. It is likely that the price of the first sales will
be provisional, until market prices stabilize.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 9.45pt"></TD><TD STYLE="width: 33.75pt; text-align: left">1O.</TD><TD STYLE="text-align: justify">Finally, SQM has made public in a clear and timely manner the risks associated with the sales prices of its various
products, and the history of said prices indicates the likelihood of said risks. For example, SQM&rsquo;s &quot;2012 Annual Report&quot;
and its &quot;Form 20-F Report&quot; stated that the prices of its products - especially KCL - are determined mainly on the basis
of world prices which, in some cases, have been subject to substantial volatility in recent years. SQM also stated that the supply
of some fertilizers or chemical products, including products sold by SQM, varies mainly as a result of production volumes from
the largest producers and their respective business strategies. Regarding the marketing of its fertilizers, SQM has indicated that
it cannot guarantee that prices and sales volumes of said products will not decline in the future.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 70.4pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 70.4pt 0pt 8.75pt; text-align: justify; text-indent: 35.15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 70.4pt 0pt 8.75pt; text-align: justify; text-indent: 35.15pt">We
are at your service to try to clarify any additional questions related to the above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 44.25pt">Best regards,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SOCIEDAD QUIMICA y MINERA de CHILE S.A.</B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 167.4pt; color: Red"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: left; margin-bottom: 0pt">MAS/vgm</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: left; margin-bottom: 0pt">FIS/030</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: left; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: left; margin-bottom: 0pt"></P>

<HR ALIGN="LEFT" NOSHADE SIZE="1" STYLE="color: Black; width: 25%; margin-top: 3pt; margin-bottom: 3pt">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: left; margin-bottom: 0pt"><SUP>2 </SUP>Estimates relative to the second quarter and the second half of 2013 are internal projections on the part
of SQM. These projections are subject to a great number of variables that are not under the control of the Company and, therefore,
the final values may vary significantly compared to the original estimations.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: left; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: left; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: left; margin-bottom: 0pt"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: left; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: left; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: left; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: left; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: left; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SOCIEDAD QUIMICA Y MINERA DE CHILE S.A.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Conf:<U> /s/ Ricardo Ramos R.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Ricardo Ramos R.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Chief Financial Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Date: August 07, 2013.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X``02D9)1@`!`0```0`!``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+#`Q-#0T'R<Y/3@R/"XS-#+_
MVP!#`0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P``1"`!O`,@#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#W^HIYX[:(
MR2N%0=S_`$I[L$0LQ`4#))["LZT0WTJW\X.S_EA&?X1_>/N::5U=[`2!KV[&
M5/V6(],C,A'\A^M*-+@8?OFGF)[O*W\A@5=Q2T<SZ`4CI5GVC8>XD8?UIG]F
M%3F&]NT]C)N'ZYK0HI\TNX&<8]4BY2>"<>DB;"?Q''Z4@U0P\7UM);?[?WT_
M[Z'3\:TJ0J",'I2OW0#4D210R,&4\@J<@T^LZ73F@=IM/D$$AY:,\QO]1V/N
M*DLK\7+M#*AAN4^_$QY^H]1[T6ZH"[1112`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`,G5W:5[73T;FYD^?GGRUY;^@_&M15`4`#`'2LB`?:/%%Y(<$
M6T"1*/0M\Q/\JV!53TM'^M00M%%%2`4444`%%%%`!5*_L!=(KQMY5S%S%*.J
MGT]P>XJ[0::;3N@*6G7IO("77RYXVV2QY^ZP_IW%7,C.,\UCWG_$OUF"]48A
MN2()L?WOX&_I4.L%AK^AX9@#-("`>#\G>KY%*6G45S?HI!2UDAA12&LS2-3?
M46OMT>Q;>Y:!><[L=ZI)M-KH!J4444@"BBB@`HHHH`****`"BBB@#'T9";O5
M9CC+W97(]%``K8K'T-PTNJ*#RM[)G]*UQ5U/B8EL+1114#"BBB@`HHHH`***
M*`*FHVBWNGSVYX+K\I]&['\\5S=Q>M=Q^'KISB1;WRIN>C;2I'YUUQ&17#>)
M<:=<S`L$C-S!>H<X`(;:_P#0UTX9<TN7^NQ,MKG1Z!JDNJ07;3(B/;W4D!"'
M@A3P?RK7KE/!<:DZO>1.7ANKV1T(.5(R1D5U=9UHJ,VD-.Z$-<YX.&+34222
M3?RDD]^:Z,USWA4;'UB+&-E_)QZ9P:(?PY_(36J9T5%%%9%!1110`4444`%%
M%%`!1110!B:4?+US68#C_6I*/HR__6K;'2L27%IXKAE/"7D!BS_MH<C]"?RK
M:%74U:?=+_(2V%HHHJ!A1110`4444`%%%%`#7947<Q`'J:XGXGV1N/"CW2CY
M[9P3C^X3@Y_2NOU"$SZ?/&OWBA*_4<C]:Q_$&-3\#7I'_+:T+?IFM\/)PJQF
MNY,U>+*/PT)/@RWST\Q\?3-=?7(?#,8\#V0]&<?^/5U]&*_CS]6..R`US^A9
MCU_7X2>/M"2#_@25OFL"Q'E>,]57@>;;PR8SUZC/Z5%/X9>GZH&=!11168PH
MHHH`****`"BBB@`HHHH`R]<LWN]/+0?\?-NPFA/^TO./Q&1^-6[*[2^LH;F/
M[LBAOIZBK!%8;L="OWD(_P");<OEB.D$A[_[I_0U:]Z/+UZ`;M%(&!`(((/2
MEJ`"BBC-`!11FC-`!112$\4`*:K7T`GTZX@`&)(F3'U%4YM?T^*0Q1R/<RCK
M';(9#^G`J`ZCJ]P?]%T8QK_>NY@GZ#)JU":U_P"`)V,SPM=66C^'TCD98859
M,=2-S_\`V0-=<#7D6OG6]-<Z<;:)F></''"KN60-O!4^QR/QKJY/$5]+=)J5
MO'*FDVJJMU&\)#L6^\1GGY>,UUUL,Y/VB?Q?U^),9=#L6-<M-="V^)$,1.!<
M6.S\0Q(_K3KOQ8L>H?Z'!]LL(45KJ>'YC'NZ8]<=35*XVZ]JVHWFFR)*UG%"
M8)4.0S@EB/Q!Q^-9TJ;C=S6C0F[[':BEJIIU]%J-C%=0GY)!G'<'N#[@U;KE
MLUHS0**,T9H`***,T`%%%%`!1110`4R2-)8VCD4,C##*1D$4^B@#@/'=O?:+
MX`UU;.5WL_LC[!OVR6_^Z>Z^W45CV\^FS:UHMKX5.J#4XKJ,WYE:?RU@V_O`
MXD.#GC&.<UZ#XGT7_A(O#6H:/Y_D?;(3%YNW=LSWQWJ>32+.XAB2Y@25XE`6
M3&&&!U!'(JN:_P`0(XV\\?W]AJ<"7=KID5O+?K9FT%X&O$5FVK(5'R@=\9S@
MUGZ=XHUS3/[<:6"&\FE\2"PMXVG;"AE`P"1PH&#_`-]5)!\*;BWM7M(O$<JV
MRW:WD`^RJ7\P2;QYC$Y?'([>M:#?#ZZ:[N91K\HBEU6/5446Z[DE4889[@C&
M../>BR[CT('\1W&CZKK.[3XY]9DDL+79'</Y4MQ(IP!N^X@`R2!DT[5]<U"W
MN=*@\0:?:QRIK$"0SVUTPCD4HQ+@<-\O0JW!S5F^^'8U&YU6XGUF\\Z\EM[B
M&0``P20@A3QPPYZ<<4EO\/Y4O(+ZYU-9;Q;^&[D9+?:FV-6`C52Q(SN)+$DF
MCW>X&>?B)K<EE_;D.A0CP\\XACGEE*R8:38LI'0J3V'..]6/&EM?O#I&GW6J
M7`?5=1CM)&MOW:11X9F"XYR0N,GUJW'X!F$,6E/K+MX>BN1<I8^0`_#[Q&9,
M\H&YQC/;-=#XAT&#Q!I?V2:66"1)%F@N(CAX95.5=?IZ=QD4U/E^$6ACV7@_
M3_#NHV=WHER^G6T89;JU,C.ERNTXR&/#@\[ASUK.M_'.K26-EK\NEVJ^';RX
M2&,K,QN41WV)*PQMP3CY0<@&M.V\+:E<ZO97VOZT-06P9GM88;40)O*[=[X)
MW-@G'0#)XJC;^`9X([72Y-:DE\/6ERMQ#8^0!)E7WK&TF>4#8.,9XY-3>[NQ
ME63QSK44+:K-I-B-*M]5;3I7$S&9AYOEAT&,`9(R">>:S8?%^I:#<>*+C4?L
MTZOK*V5FCW#!4<H.&)&%C"\G'.<^U=)<>"6N/#,^COJ',NI?;_.$73]^)=N,
M^V,U%=>`GN;S5)1JK1)=7L>HVI6`%[6Y4!2V2<.I`QM([GFD&AC6WQ"%GI>L
M)!9Z3=7=G%'<!]+D9K=TD?86?Y=R[#RW!XZ5:C\;3V'A2^U*"RTF=8KF.)+G
M3IM]L0^,R.%!=`F3N!&>.*UAX3U6:TO/M7B2=;Z<1B*:TMUAC@V-N&$R=VX_
M>R>1Q5>W\"W4:ZC=-K1@U6]:!C<V-JL*+Y1)`,>3N#9.[)Y'':G=AH8,GBZ[
MTK2GUJU?2G^U7Z6J"&Z#6=P6&?-W<M$0,Y!SR/?-:?A;XF1ZIJ%WIVJ1P1SP
M1B59[(M+$ZDX(Z'!!_`YJQ'\/-UO?33:H4U2YNH;M+FTM5B2&2($(5CY!X)W
M9/.:WM&T2_L[Z>^U'6'O9I(UB6..$0PQJ#G(0$Y8GJ2?:JYD_B0CDKC5-*\3
M>,-3M]5U)ET;3(8O*M1*\2SR.I9G?!!8`8`!XZU-X*USPW_;-];Z-KDYL7A2
M9+"\21!`<D%D>7G:>/E[$9K?U?PQ)<ZN-8TK4WT[46C$,S>2LT5P@.0'0XY&
M3@@@\FJ</@A_.O\`4+O4UNM8N;?[/'<O91B*W4'(VQ=#R<_,232O`#JX[JWE
M`,<\3@_W7!JM?V4E^8T6\E@@Y\Q83AG]!NZ@?2JZ^&M):-!+IUJ\@`#.(@NX
MXY.!TIO_``B^D`Y2U:,_],Y77^1IIP3O=_<+4U88U@A2)`0J#`R<_J:DS6)_
MPC5NG^HOM2@_W+IB/R.:0Z)?*?W>OWX'HRQM_P"RT*,']K\`U-O(HK%@T[6(
MKI6DUPS0`C]VUJ@)'IN%%3));/\`K[@N;=%%%(84444`<QKFL:DVO6GA_13!
M'=S0M<W%U.A=;>$':"%!&YF8X`)QP:+"YUW3-3F@U>[M;[2Q;M-_:"HL)@9>
MJNNXY!&2".F#FF:[IFIVOB2U\1Z+;I=S);FSN[-Y1&98BVY2C'@,K9Z\$$US
M3^"[C6=4O+JVT2#0K>>QNX&=IA))<2S@#<P4D``@GKGGM0!U>G>-M+U&>&*-
M+R+[1&TEJ]Q:M&MRJC)\LGKQSC@XYJ"#X@:-<V$5["E\T$Y1;;%JVZY9L_+&
M.K$8.>PQUKGM*\.:D]]I/VG0YX'T]6>::XU5IT$@C*+Y*;CUS_$!@<4Q_"&J
MCPQX/<VCRW6D1LEU9PW?DLRNNUBDBD#<"`>N#S0.QU+^.]$ATU[Z>2XA6*Z2
MTFBD@82PRM]T,G7G(Y&<YXK*\0?$6&R\-ZK>6-M=+J%A+%');75JRL@D8!7*
M]=I&<'UP*S%\*:BR?:4TG[,TVL6<[1S7IGE,$/\`'(S,1GGA5/3'6IO%/AG6
M-0O/%DUI;+(MY:V(M@9%7S&AD+NO)XX[GB@:2.BO?&^EV,S1217\C10K/<B&
MT=_LJ,,@RX^Z<<XZX[5I:EKMGIWAJXUUI!)90VQN=\9SO3;D8^O'YUP=YX;U
M5-9U?4$TB[NTU@1W$21:I]G\B7RPACE`8!EXSN7=QD5UI\,17/@$>&;D)%&]
MB+5_))98SMQ\N[D@'IGTH),C=XY?25U@7^GB[>+SDT;[-\A&,^7YI;=NQQNQ
MC/;%:][XPL]/GBM9;6^GO6@6>:VL[<SM;H>[[>`,Y'OCBN:U/3=>U;2(M)U3
MPG:7U_!"T$.HF\00#<NTR[3\X/`.,'GH>]5)O!>HZ7J:S_8KK589;"UMV-GJ
M36C)-"FWD;@&5NN<DCGB@#K+CQWH\?V-;?[5?27MLUU:QV=NTC3(I`(`[$9Y
M!QC!H/CK2&TRQO;?[5=F^WBWMK:W9YW*'#@IVVG@YQBLGPSX9OM&UO1WEM((
M8+?2YXI?)E+JDLDPD*@L=QXSSZUSJ>"=7@AL+Z;3IKC[/+?Q3VEM?_9Y3'-.
M9$=7#`'W4D=?6@;1V\WCS1H;*SNO]*?[5</:I"ELQE6=5),3)U#<8QZX[<U#
M>?$/2;+S#+:ZF4MT1[QTM&9;/<`0)2/NL`<D#..]8&G^$]3M9M"N!IRVVW6I
M+VXC:\,[QQF%D4N[L=S],[>/RS5?Q-X;\4:Q<>(K(VL]U'>*WV"0:B(;6./8
M``\2D,SYSR00<CD`4PL=?I&LW-]XUUS3S(CV-I;VLEOM49S(K%CGOG`KIA7'
M^&-)O[/Q-JM_=6_E0W5E9)'\ZL=R(P<'![$CZ]J["D)H****`*]Y>VUA;M/=
M3)%&O=CU]AZFG6EP+NUCN%1T61=P61=K8]QVK,U2QEEU;3[U8O/C@9E:(L!M
4W?QC/!(K8'2J:22MN`M%%%2!_]D_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
